Table 1.
Clinical and pathological characteristics of the included patients
| Clinical values | IgAN (n = 68) |
|---|---|
| Age, yr, mean (SD) | 42.28 (18.75) |
| Serum creatinine, mg/dL, mean (SD) | 0.97 (0.53) |
| Urinary protein, g/day or protein/creatinine ratio, mean (SD) | 1.37 (1.92) |
| Systolic blood pressure, mm Hg, mean (SD) | 124.13 (17.23) |
| Male gender, n (%) | 27 (39.7) |
| Urinary occult blood, n (%) | |
| − | 4 (5.9) |
| ± | 5 (7.4) |
| 1+ | 3 (4.4) |
| 2+ | 28 (41.2) |
| 3+ | 28 (41.2) |
| M = 1, n (%) | 28 (41.2) |
| E = 1, n (%) | 9 (13.2) |
| S = 1, n (%) | 52 (76.5) |
| T, n (%) | |
| 0 | 57 (83.8) |
| 1 | 9 (13.2) |
| 2 | 2 (2.9) |
| C, n (%) | |
| 0 | 30 (44.1) |
| 1 | 37 (54.4) |
| 2 | 1 (1.5) |
C, cellular or fibrocellular crescents; E, endocapillary hypercellularity; IgAN, IgA nephropathy; M, mesangial hypercellularity; S, segmental glomerulosclerosis; SD, standard deviation; T, interstitial fibrosis/tubular atrophy.